.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Federal Trade Commission
Teva
Fish and Richardson
Merck
Julphar
US Department of Justice
McKinsey
Fuji
Boehringer Ingelheim

Generated: June 23, 2017

DrugPatentWatch Database Preview

ORETICYL 50 Drug Profile

« Back to Dashboard

What is the patent landscape for Oreticyl 50, and when can generic versions of Oreticyl 50 launch?

Oreticyl 50 is a drug marketed by Abbvie and is included in one NDA.

The generic ingredient in ORETICYL 50 is deserpidine; hydrochlorothiazide. There are four drug master file entries for this compound. Additional details are available on the deserpidine; hydrochlorothiazide profile page.

Summary for Tradename: ORETICYL 50

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list28
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ORETICYL 50 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie
ORETICYL 50
deserpidine; hydrochlorothiazide
TABLET;ORAL012148-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
McKesson
Merck
Farmers Insurance
McKinsey
Chubb
Covington
Accenture
Colorcon
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot